2021 Child Asthma Data: Prevalence Tables

\

Table L2_1
Childa Lifetime Asthmab Prevalence
by Sex at Birth and State or Territory: BRFSS 2021
State Male Sample Sized Male Prevalence Male Standard Error Male 95% CIe || Female Sample Sized Female Prevalence Female Standard Error Female 95% CIe
Totalf 26,887 10.9 0.42 (10.1–11.8) || 25,058 9.5 0.48 (8.6–10.4)
CA 754 8.9 1.26 (6.7–11.7) || 666 8.2 1.56 (5.7–11.9)
CT 866 15.0 2.12 (11.3–19.7) || 847 12.2 1.62 (9.4–15.8)
DC 256 17.2 3.23 (11.8–24.5) || 216 15.2 3.25 (9.8–22.7)
GA 641 13.3 1.92 (10.0–17.6) || 663 15.4 2.60 (10.9–21.2)
HI 821 9.9 1.78 (6.9–13.9) || 714 6.5 1.65 (4.0–10.6)
IL 248 8.2 2.00 (5.0–13.1) || 224 9.9 3.22 (5.1–18.2)
IN 984 11.2 1.17 (9.1–13.7) || 925 9.2 1.33 (6.9–12.1)
KS 2,145 11.6 0.89 (10.0–13.5) || 1,954 9.3 0.81 (7.9–11.1)
KY 506 9.4 1.63 (6.7–13.1) || 447 7.1 1.34 (4.9–10.2)
ME 849 14.9 2.02 (11.4–19.3) || 799 6.8 1.12 (4.9–9.3)
MD 1,591 11.5 1.27 (9.2–14.2) || 1,488 10.1 1.19 (8.0–12.7)
MA 651 17.3 2.11 (13.6–21.8) || 650 11.0 1.86 (7.8–15.2)
MI 843 12.7 1.53 (10.0–16.1) || 729 8.0 1.29 (5.8–10.9)
MN 1,696 10.5 1.09 (8.5–12.8) || 1,514 6.9 0.94 (5.3–9.0)
MS 500 15.6 2.46 (11.3–21.0) || 445 11.1 1.97 (7.8–15.6)
MO 1,331 13.5 1.63 (10.6–17.0) || 1,211 8.6 1.36 (6.2–11.6)
MT 666 8.6 1.34 (6.3–11.6) || 577 7.0 1.21 (5.0–9.7)
NE 1,570 9.1 1.18 (7.0–11.6) || 1,539 6.3 0.90 (4.8–8.3)
NH 416 11.5 1.87 (8.3–15.7) || 387 10.6 1.78 (7.6–14.6)
NJ 829 11.0 1.63 (8.2–14.6) || 772 6.2 0.97 (4.5–8.4)
NM 728 10.7 1.50 (8.1–14.0) || 651 7.1 1.34 (4.9–10.2)
NY 1,070 10.8 1.59 (8.0–14.3) || 1,053 8.6 1.44 (6.2–11.9)
OH 1,291 8.8 1.06 (7.0–11.1) || 1,159 8.5 1.24 (6.4–11.3)
PA 579 12.7 2.12 (9.1–17.5) || 540 8.6 1.26 (6.5–11.5)
RI 607 11.5 1.72 (8.6–15.4) || 537 8.5 1.59 (5.9–12.2)
TX 1,125 10.3 1.44 (7.8–13.5) || 1,080 12.0 1.75 (9.0–15.9)
UT 1,612 10.2 1.00 (8.4–12.4) || 1,587 6.4 0.69 (5.2–7.9)
VT 634 9.4 1.62 (6.6–13.1) || 645 7.7 1.25 (5.6–10.6)
WI 517 10.1 1.62 (7.3–13.7) || 504 10.5 3.05 (5.8–18.1)
Territory
PR 434 19.5 2.23 (15.5–24.3) || 453 16.1 2.01 (12.6–20.5)
VI 123 16.1 5.85 (7.6–31.0) || 115 9.0 4.85 (3.0–24.0)

 

For additional information on methods and variable description, refer to “Technical Information, available at: https://www.cdc.gov/asthma/brfss/2021/child/brfsschildtechinfo.html
aAged 0-17 years
bLifetime question: Has a doctor, nurse or other health professional ever said that the child has asthma?
cWeighted number of respondents who answered the lifetime asthma question
dUnweighted number of respondents who answered the lifetime asthma question
eCI denotes confidence interval
fTotal includes data from 29 states and DC, but excludes Puerto Rico and U.S. Virgin Islands
(.–.) or empty cell: Suppressed if the normal approximation to the binomial distribution does not apply due to small sample size or relative standard error (RSE) > 30%

Asthma and Community Health Branch, National Center for Environmental Health
Centers for Disease Control and Prevention

View Page In: PDF - 133 KB